A randomized, double-blinded, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and biological activity of ATYR1940 in adult patients with facioscapulohumeral muscular dystrophy (FSHD)
Title:
A randomized, double-blinded, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and biological activity of ATYR1940 in adult patients with facioscapulohumeral muscular dystrophy (FSHD)
Author:
Gershman, A. Chiang, K. Do, M. Abbink, E. Harbers, V. Audebert, C. Campana-Salort, E. Monforte, M. Iyadurai, S. Carey, L. Heskamp, L. Kan, H. Heerschap, A. Kissel, J. Ricci, E. Attarian, S. Blackburn, K. Mendlein, J. Ashlock, M.